SIRPA and neoplasm: As shown in Fig. 2c, both Cl2MDA-liposomes and αCSF1R antibodies abrogated the efficacy of RT with respect to suppressing tumor growth in and enhancing the survival rate of Sirpα−/− mice, suggesting a key role for intratumoral Sirpα−/− macrophages in responding to RT.